今年6月7日,渤健(Biogen)基于β-淀粉样蛋白假说而开发的第一款用于治疗AD的单克隆抗体药物Aduhelm历经波折,终获得美国FDA批准上市,是近20年来AD领域首款新疗法...查看全文
$Trident(TDAC)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0001213900-21-010982 Act: 34 Size: 842 KB 网页链接
$Trident(TDAC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001140361-21-004647 Act: 34 Size: 196 KB 网页链接
$Trident(TDAC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001213900-21-007456 Act: 34 Size: 44 KB 网页链接
$Trident(TDAC)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-21-007455 Act: 34 Size: 44 KB 网页链接
$Trident(TDAC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001076809-21-000012 Act: 34 Size: 58 KB 网页链接
$Trident(TDAC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001076809-21-000014 Act: 34 Size: 58 KB 网页链接
$Trident(TDAC)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001213900-20-041822 Act: 34 Size: 51 KB 网页链接
$Trident(TDAC)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-20-041821 Act: 34 Size: 51 KB 网页链接
$Trident(TDAC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001393825-20-000140 Act: 34 Size: 58 KB 网页链接
$Trident(TDAC)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001213900-20-041075 Act: 34 Size: 283 KB 网页链接